The Duke Human Vaccine Institute Genomics core facility provides sequencing and genomic technologies to serve the needs of the Duke Human Vaccine Institute, Duke Center for AIDS Research, Duke University and external collaborators.
We offer automated amplicon purification, a suite of next-generation DNA/RNA bulk sequencing, and single-cell genomic technologies. We also are available to provide project consultation and sequencing analysis. We perform and provide state-of-the-art genome and transcriptome sequencing and high-throughput sequencing of antibody receptor and viral genes. Administratively, we provide project consultation and sequencing analysis.
In addition to basic sequencing, extensive analysis of sequence data is also offered.
